Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry (“MS”) instruments, is pleased to announce that it has signed an agreement with Omicron Research Ltd. (“Omicron”) to distribute Microsaic’s 4500 MiD® MS detector via Omicron’s distribution network in the United Kingdom. Omicron is a UK distributor for a range of scientific instrumentation […]

Siemens becomes a preferred supplier for automation solutions Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future New automated product to debut at the ACHEMA 2018 trade show in Frankfurt Göttingen and Munich, Germany/ — The Siemens technology group and Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical […]

New Partnership with Challentech International strengthens support of Picarro SI2000 Series gas analyzers in the APAC region Santa Clara, CA — Picarro Inc., a leading provider of trace gas analyzers for a variety of air monitoring applications, today announced an exciting new partnership with the highly regarded Taiwanese distributor, Challentech International Corporation. The agreement involves […]

Vienna, Austria, and Rijswijk, The Netherlands – Lexogen, a transcriptomics and next-generation sequencing company and Bluebee, a global bioinformatics platform, have announced today the implementation of QuantSeq Unique Molecular Identifiers (UMI) data analysis pipeline on the Bluebee genomics analysis platform. This collaboration offers QuantSeq users utilizing UMIs the opportunity to analyze samples in a convenient and rapid manner […]

Biocept’s patented collection tubes now available from VWR for the safe transport of patient specimens containing both circulating cell-free DNA (cfDNA) and circulating tumor cells (CTCs) at room temperature SAN DIEGO — Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of […]

To promote the Cancer Research Institute’s global awareness campaign, Cancer Immunotherapy Month, ACEA Biosciences will be participating in the #WearWhite campaign on June 15 and providing an Immunotherapy Research Grant to help scientists in the field of cancer research achieve their goals. As a leading innovator in the development of tools for the cancer research […]

Under this agreement, MaxCyte’s second signed with a U.S. NIH institute in the past year, the Company and the National Heart, Lung, and Blood Institute will explore development of new therapies for sickle cell disease using MaxCyte’s gene-correction platform   Gaithersburg, Maryland – MaxCyte, Inc. today announces it has entered into a Cooperative Research and Development Agreement (“CRADA”) […]

NGS-based microbiome profiling delivers enhanced insights for metagenomics studies Gut bacteria play an important role in human health, as changes in the microbiome can be potentially harmful, and may be associated with chronic conditions such as inflammatory bowel disease, obesity and cancer.* Next-generation sequencing (NGS) technologies can deliver the necessary details to characterize microbial communities, […]

Joint offering enables acceleration of genomic panel design for translational and clinical disease research SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation announced today that it has entered into a co-marketing agreement with Genomenon to offer evidence-based genomic panel design services for translational and clinical disease research. The rapidly expanding knowledge base of genes and variants associated with […]

Zymo Research and CosmosID announce their partnership to provide microbiome researchers with an integrated end to end solution for accurate microbiome analysis.   The partnership combines Zymo Research’s complete microbiomics product portfolio from sample collection/preservation, mock microbial community standards, nucleic acid isolation, and library preparation with the largest curated microbiome database maintained and powered by CosmosID. The combined technologies of […]